|1.||Pečivová, Jana: 1 article (03/2011)|
|2.||Perečko, Tomáš: 1 article (03/2011)|
|3.||Ambrožová, Gabriela: 1 article (03/2011)|
|4.||Cíž, Milan: 1 article (03/2011)|
|5.||Moravcová, Jana: 1 article (03/2011)|
|6.||Nosál, Radomír: 1 article (03/2011)|
|7.||Lojek, Antonin: 1 article (03/2011)|
|8.||Vašíček, Ondřej: 1 article (03/2011)|
|9.||Kubala, Lukáš: 1 article (03/2011)|
|10.||Pekarová, Michaela: 1 article (03/2011)|
01/01/1988 - "This study shows that acrivastine is an effective agent in the treatment of cold urticaria and suggests that acrivastine in the dose used lacks adverse effects, such as drowsiness, traditionally associated with antihistamine therapy."
01/01/1984 - "Both doses of BW 825C were found to be highly effective and significantly better than placebo in controlling signs and symptoms of urticaria. "
01/01/1984 - "An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. "
06/01/1991 - "Double-blind clinical trials have shown acrivastine (usually 8mg three times daily) to be an effective and well tolerated antihistamine in the treatment of chronic urticaria and allergic rhinitis. "
01/01/1989 - "Both acrivastine and hydroxyzine were found to be effective, and significantly better than placebo, in controlling signs and symptoms of urticaria. "
04/01/2000 - "Both antihistamine-decongestant combinations demonstrate an onset-of-action within 60 minutes of administration but under conditions of higher pollen exposure, the acrivastine combination was more effective for total symptoms, rhinitis symptoms, and nasal congestion with an onset-of-action within 45 minutes for rhinitis symptoms and 15 minutes for congestion."
09/01/1994 - "Efficacy of acrivastine in the treatment of allergic rhinitis during natural pollen exposure: onset of action."
01/01/1989 - "The marked absence of other signs of significant depression of the central nervous system (or anticholinergic activity) suggests that acrivastine will be an important addition for the antihistaminic control of symptoms of allergic rhinitis."
01/01/1989 - "This comprehensive review of clinical experience with acrivastine in allergic rhinitis considers all currently available data both published and, as yet, unpublished. "
01/01/1989 - "Acrivastine in allergic rhinitis: a review of clinical experience."
|3.||Seasonal Allergic Rhinitis (Hay Fever)
01/01/1989 - "Acrivastine was both well tolerated and effective in the treatment of seasonal allergic rhinitis."
01/01/1989 - "Unequivocal evidence of the efficacy of 8 mg acrivastine three times daily for the control of symptoms of seasonal allergic rhinitis has been provided by 11 placebo-controlled studies involving almost 1000 patients. "
01/01/1989 - "Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis."
01/01/1989 - "In a double-blind, placebo-controlled multicentre study, the antihistamine acrivastine, was used over prolonged periods for the treatment of seasonal allergic rhinitis. "
11/01/1988 - "One study on 31 patients found both 4 and 8 mg acrivastine given three times daily to be significantly better than placebo for alleviating hay fever. "
01/01/1994 - "Ten subjects with a well-documented allergy to pollen received single doses of 8 mg of acrivastine and placebo according to a randomized, double-blind, placebo-controlled, crossover treatment design. "
02/01/1996 - "The objective of the study was to demonstrate that both acrivastine and pseudoephedrine share in the efficacy of the combination in relieving allergy symptoms in patients sensitive to ragweed pollen. "
01/01/2006 - "A randomized, double-blind, placebo-controlled study was performed in which Ze 339 was compared to acrivastine, a short-acting antihistamine, in 8 patients with respiratory allergy and in 10 nonatopic, healthy volunteers. "
02/01/1996 - "Patients who qualified for the study were dispensed either (1) acrivastine + pseudoephedrine, (2) acrivastine, (3) pseudoephedrine, or (4) placebo with instructions to take one capsule 4 times daily and to record allergy symptom scores in a symptom diary 3 times daily for 14 days. "
03/01/1996 - "Atopic subjects with allergies treated with acrivastine + pseudoephedrine learned as well as normal subjects."
|5.||Clemastine (Clemastine Fumarate)
|7.||Histamine (Histamine Dihydrochloride)